Mon, August 13, 2012
[ Mon, Aug 13th 2012 ] - Market Wire
Erich R. Reinhardt Appointed to Board of Directors of Varian Medical Systems
[ Mon, Aug 13th 2012 ] - Market Wire
Varian Medical Systems' CEO Timothy E. Guertin An .. 59; Board of Directors Names Dow R. Wilson as Suc
[ Mon, Aug 13th 2012 ] - Market Wire
USANA Health Sciences Supports Mexico National Soccer
[ Mon, Aug 13th 2012 ] - Market Wire
ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2012
[ Mon, Aug 13th 2012 ] - Market Wire
ImmuCell Announces Profitable Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
ProMetic Reports Its Second Quarter 2012 Highlights and Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
Implant Sciences Announces New Sales to Nigeria for Aviation Security
[ Mon, Aug 13th 2012 ] - Market Wire
Adherex Reports Recent Developments and Second Quarter June 30, 2012 Financial Results
[ Mon, Aug 13th 2012 ] - Market Wire
Comprehensive Care Corporation Announces Profitable Six Month Financial Results
Fri, August 10, 2012
[ Fri, Aug 10th 2012 ] - Market Wire
Quidel Secures New $140 Million Credit Facility
[ Fri, Aug 10th 2012 ] - Market Wire
Remedent Announces Conference Call to Be Held on .. PM EDT to Give an Update on Recent Strategic Dev
[ Fri, Aug 10th 2012 ] - Market Wire
Vivakor Announces Alternative Energy Asset Acquisition Strategy
[ Fri, Aug 10th 2012 ] - Market Wire
PharmAthene Receives FDA Notification On SparVaxa"
[ Fri, Aug 10th 2012 ] - Market Wire
MultiCell Technologies Updates Preclinical Result .. d MCT-485 in Primary Liver Cancer in vitro Models
[ Fri, Aug 10th 2012 ] - Market Wire
NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference
[ Fri, Aug 10th 2012 ] - Market Wire
Soligenix Reports Second Quarter 2012 Financial Results and Highlights Recent Accomplishments
[ Fri, Aug 10th 2012 ] - Market Wire
Mylan Launches Generic Version of Provigil Tablets
[ Fri, Aug 10th 2012 ] - Market Wire
Biodel to Present at 2012 Wedbush PacGrow Lifesciences Management Access Conference
[ Fri, Aug 10th 2012 ] - Market Wire
Lexicon Pharmaceuticals To Present At The Wedbush PacGrow 2012 Management Access Conference
[ Fri, Aug 10th 2012 ] - Market Wire
Reliv's ProVantage Performance Supplement Adds LunaRich, Earns Patent
Thu, August 9, 2012
[ Thu, Aug 09th 2012 ] - Market Wire
NuPathe to Report Second Quarter 2012 Results and Hold Conference Call on Tuesday, August 14, 2012
[ Thu, Aug 09th 2012 ] - Market Wire
Cytomedix to Host Second Quarter 2012 Financial R .. lts Conference Call on Wednesday, August 15, 2012
[ Thu, Aug 09th 2012 ] - Market Wire
Sun Healthcare Group, Inc. Announces Expiration o .. eriod in Connection With Proposed Transaction Wit
[ Thu, Aug 09th 2012 ] - Market Wire
Oncothyreon Reports Second Quarter 2012 Financial Results
[ Thu, Aug 09th 2012 ] - Market Wire
Department of Defense Exercises Options Under Con .. ct for Nerve Agent Medical Countermeasure Program
[ Thu, Aug 09th 2012 ] - Market Wire
Mesa Labs Reports 25% Increase in First Quarter Net Income
[ Thu, Aug 09th 2012 ] - Market Wire
Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin Injection
[ Thu, Aug 09th 2012 ] - Market Wire
Cynosure to Present at Canaccord Genuity 32nd Annual Growth Conference
[ Thu, Aug 09th 2012 ] - Market Wire
Cytori Expands European Approval for Celution(R) .. ncluding Intractable Cryptoglandular Fistulae;
[ Thu, Aug 09th 2012 ] - Market Wire
Isis Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Growth Conference
[ Thu, Aug 09th 2012 ] - Market Wire
Fanapta" is Granted Market Approval in Israel for the Treatment of Schizophrenia
Wed, August 8, 2012
[ Wed, Aug 08th 2012 ] - Market Wire
Nordion Statement on Voluntary Disclosure
[ Wed, Aug 08th 2012 ] - Market Wire
Liazon's Private Exchange Expands Aetna Offerings in Key Markets
[ Wed, Aug 08th 2012 ] - Market Wire
MEI Pharma to Acquire Pracinostat, a Potential Best-in-Class HDAC Inhibitor
[ Wed, Aug 08th 2012 ] - Market Wire
Syneron to Present at the Canaccord Genuity Growth Conference
[ Wed, Aug 08th 2012 ] - Market Wire
Lightlake Therapeutics Inc. Announces Positive Fi .. Trial Results of Binge Eating Disorder Treatment
[ Wed, Aug 08th 2012 ] - Market Wire
AspenBio Pharma to Provide Shareholders with Business Update
[ Wed, Aug 08th 2012 ] - Market Wire
Equity Research on Raptor Pharmaceuticals Corp. a .. s Inc. - Strong Quarter for Diagnostic Substances
[ Wed, Aug 08th 2012 ] - Market Wire
Oncothyreon Announces Second Quarter 2012 Financial Results Conference Call
[ Wed, Aug 08th 2012 ] - Market Wire
AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
[ Wed, Aug 08th 2012 ] - Market Wire
Uroplasty To Participate In Two Upcoming Conferences
[ Wed, Aug 08th 2012 ] - Market Wire
Lorus Therapeutics Reports Results for Fiscal Year 2012
Tue, August 7, 2012
[ Tue, Aug 07th 2012 ] - Market Wire
Theratechnologies Receives Notification from NASDAQ Relating to Minimum Bid Price
[ Tue, Aug 07th 2012 ] - Market Wire
Islet Sciences Announces Strategic Alliance with Spring Point Project
[ Tue, Aug 07th 2012 ] - Market Wire
Hangover Joe's The Hangover Recovery Shot Now Available in Canada
[ Tue, Aug 07th 2012 ] - Market Wire
ProMetic to Report Second Quarter 2012 Financial Results and Hold Conference Call/Webcast
[ Tue, Aug 07th 2012 ] - Market Wire
MiMedx Group Announces Positive Results From Diabetic Foot Ulcer Randomized Controlled Trial
[ Tue, Aug 07th 2012 ] - Market Wire
Corcept Therapeutics Announces $30 Million Synthe .. on;; Terminates Committed Equity Financing
[ Tue, Aug 07th 2012 ] - Market Wire
AspenBio Pharma Submits Pre-IDE Information Packa .. e to FDA for AppyScorea" Appendicitis Test System
[ Tue, Aug 07th 2012 ] - Market Wire
Aeterna Zentaris Granted Patent in the U.S. for A .. agnostic Test for Adult Growth Hormone Deficiency
[ Tue, Aug 07th 2012 ] - Market Wire
Rigel Announces Second Quarter 2012 Financial Results
[ Tue, Aug 07th 2012 ] - Market Wire
EnteroMedics Reports Second Quarter 2012 Financial Results
[ Tue, Aug 07th 2012 ] - Market Wire
Luminex Corporation y el University Hospital of Wales colaboran durante los Juegos Olmpicos
Mon, August 6, 2012
[ Mon, Aug 06th 2012 ] - Market Wire
MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
[ Mon, Aug 06th 2012 ] - Market Wire
ViroPharma Receives FDA Approval of Cinryze (C1 E .. Inhibitor [Human]) Industrial Scale Manufacturing
[ Mon, Aug 06th 2012 ] - Market Wire
Zondan Partners with Masimo to Incorporate Signal .. inbow Across Entire Portfolio of Patient Monitors
[ Mon, Aug 06th 2012 ] - Market Wire
Equity Research on CareFusion Corp. and Stryker C .. arnings Shake Up Medical Instruments and Supplies
[ Mon, Aug 06th 2012 ] - Market Wire
SearchCore Announces Executive Resignations
[ Mon, Aug 06th 2012 ] - Market Wire
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
[ Mon, Aug 06th 2012 ] - Market Wire
EnteroMedics to Present at 32nd Annual Canaccord Genuity Growth Conference
[ Mon, Aug 06th 2012 ] - Market Wire
Luminex Corporation et l'h'pital universitaire du .. Galles s'associent l'occasion des Jeux olympiques
[ Mon, Aug 06th 2012 ] - Market Wire
ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
[ Mon, Aug 06th 2012 ] - Market Wire
Savient Pharmaceuticals Adopts Stockholder Rights Plan
[ Mon, Aug 06th 2012 ] - Market Wire
Sunshine Heart Announces Conditional Approval Fro .. for Its Next Generation C-Pulse(R) System Driver
Fri, August 3, 2012
[ Fri, Aug 03rd 2012 ] - Market Wire
Biostar Pharmaceuticals, Inc. Receives Approval F .. ng SFDA To Restart Sales Of Its Gel Capsule Drugs
[ Fri, Aug 03rd 2012 ] - Market Wire
Medivation and Astellas Announce PDUFA Action Date for Enzalutamide NDA
[ Fri, Aug 03rd 2012 ] - Market Wire
DiaMedica Accelerates Warrant Expiry Date
[ Fri, Aug 03rd 2012 ] - Market Wire
SoloHealth and WellPoint Announce Strategic Relat .. lp Make Consumers More Aware, Empowered & Healthy
[ Fri, Aug 03rd 2012 ] - Market Wire
Gemoscan Canada Announces Convertible Debenture Financing
[ Fri, Aug 03rd 2012 ] - Market Wire
Pro-Dex, Inc. Announces Update Conference Call and Webcast
[ Fri, Aug 03rd 2012 ] - Market Wire
Avanir Pharmaceuticals Announces Listing Of Additional NUEDEXTA Patent In FDA Orange Book
[ Fri, Aug 03rd 2012 ] - Market Wire
Daxor Announces Sale of BVA-100 Blood Volume Analyzer and Payment of a Dividend
[ Fri, Aug 03rd 2012 ] - Market Wire
Bioheart Renegotiates Company Note With Favorable Terms
[ Fri, Aug 03rd 2012 ] - Market Wire
Marina Biotech Announces Worldwide Non-Exclusive Licensing Agreement for Nucleic Acid Chemistry
[ Fri, Aug 03rd 2012 ] - Market Wire
Concord Medical to Report Second Quarter 2012 Financial Results on August 20, 2012
Thu, August 2, 2012
[ Thu, Aug 02nd 2012 ] - Market Wire
Nektar to Announce Financial Results for the Seco .. y, August 9, 2012, After Close of U.S.-Based Fina
[ Thu, Aug 02nd 2012 ] - Market Wire
MSA Declares Third Quarter Dividend
[ Thu, Aug 02nd 2012 ] - Market Wire
Mylan Signs Agreement with Gilead to Accelerate A .. ixed-Dose Combination ARVs Containing Emtricitabi
[ Thu, Aug 02nd 2012 ] - Market Wire
Waters and Nonlinear Dynamics to Co-Develop Next .. arch Solutions for Large-Scale, Complex Data Sets
[ Thu, Aug 02nd 2012 ] - Market Wire
Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
[ Thu, Aug 02nd 2012 ] - Market Wire
Accuray Announces First CyberKnife System in South America
[ Thu, Aug 02nd 2012 ] - Market Wire
ZYTO Corp Announces Expansion of Scientific Advisory Board
[ Thu, Aug 02nd 2012 ] - Market Wire
Bioheart Receives $ 2 Million Term Sheet Investme .. bal Leader in Healthcare in Latin America and Eur
[ Thu, Aug 02nd 2012 ] - Market Wire
Implant Sciences Awarded Follow-On Order to China for Aviation Security
[ Thu, Aug 02nd 2012 ] - Market Wire
00 p.m. EDT
[ Thu, Aug 02nd 2012 ] - Market Wire
Comprehensive Care Corporation Names Colonel Ramo .. Advisor To Maximize its Market Share with New Pha
Wed, August 1, 2012
[ Wed, Aug 01st 2012 ] - Market Wire
Sarepta Therapeutics to Present Company Overview .. e 32nd Canaccord Genuity Annual Growth Conference
[ Wed, Aug 01st 2012 ] - Market Wire
Isis And Collaborators Alleviate Disease In Animal Models Of Myotonic Dystrophy
[ Wed, Aug 01st 2012 ] - Market Wire
Pharmacyclics Triggers Significant Milestone Payment and Provides Clinical Program Update
[ Wed, Aug 01st 2012 ] - Market Wire
Eternity Healthcare Receives Regulatory Approval in Canada for its Needle-Free Injection Device
[ Wed, Aug 01st 2012 ] - Market Wire
Lpath Appoints Daniel L. Kisner, M.D. to Board of Directors
[ Wed, Aug 01st 2012 ] - Market Wire
Head of European Operations
[ Wed, Aug 01st 2012 ] - Market Wire
AcelRx Pharmaceuticals Receives Two Additional U. .. s for Small-Volume Oral Transmucosal Dosage Forms
[ Wed, Aug 01st 2012 ] - Market Wire
Ampio announces successful Pre-IND meeting with t .. the FDA on Optinaa" for the treatment of Diabetic
[ Wed, Aug 01st 2012 ] - Market Wire
Die Familie der INGENIO-Herzschrittmacher erhlt die CE-Kennzeichnung fr den Einsatz bei MRT-Scans
[ Wed, Aug 01st 2012 ] - Market Wire
La famiglia di pacemaker INGENIO di Boston Scient .. er la sua compatibilit con la risonanza magnetica
[ Wed, Aug 01st 2012 ] - Market Wire
La familia de marcapasos INGENIO de Boston Scient .. ra su uso durante las pruebas de resonancia magnt
Tue, July 31, 2012
[ Tue, Jul 31st 2012 ] - Market Wire
Pharming Secures EUR10 Million Working Capital Facility From Existing Investors
[ Tue, Jul 31st 2012 ] - Market Wire
New York Genome Center Purchases Four Ion Protona" Sequencers for its new Innovation Center
[ Tue, Jul 31st 2012 ] - Market Wire
Fresh Start Private Announces New Web Presence
[ Tue, Jul 31st 2012 ] - Market Wire
China Cord Blood Corporation Files its Annual Report on Form 20-F
[ Tue, Jul 31st 2012 ] - Market Wire
Zynex Schedules Second Quarter 2012 Earnings Release and Webcast
[ Tue, Jul 31st 2012 ] - Market Wire
Aethlon Medical Reports Undetectable Hepatitis C .. Initiation of Hemopurifier Therapy in Genotype-1
[ Tue, Jul 31st 2012 ] - Market Wire
CMC Biologics Acquires XOMA's Bay Area Manufacturing Facility
[ Tue, Jul 31st 2012 ] - Market Wire
La Jolla Pharmaceutical Company Announces FDA Agr .. Clinical Trial of GCS-100 in Chronic Kidney Disea
[ Tue, Jul 31st 2012 ] - Market Wire
Omeros Announces Discovery in MASP-2 Program
[ Tue, Jul 31st 2012 ] - Market Wire
FDA Accepts NuPathe's Migraine Patch NDA Resubmission for Filing
[ Tue, Jul 31st 2012 ] - Market Wire
Novadaq to Present at the Canaccord Genuity 32nd Annual Growth Conference
Mon, July 30, 2012
[ Mon, Jul 30th 2012 ] - Market Wire
Acura Pharmaceuticals Announces Second Quarter 2012 Financial Results
[ Mon, Jul 30th 2012 ] - Market Wire
Sanofi Pasteur to add 2D barcode to six more vaccines
[ Mon, Jul 30th 2012 ] - Market Wire
CFA Commentary on Sunshine Biopharma, Inc. (OTCBB: SBFM)
[ Mon, Jul 30th 2012 ] - Market Wire
New Published Paper Shows Efficacy of Lpath's Ant .. Antibody, Lpathomab, in Spinal Cord Injury Models
[ Mon, Jul 30th 2012 ] - Market Wire
Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
[ Mon, Jul 30th 2012 ] - Market Wire
Equity Research on Forest Laboratories Inc. and E .. atent Expiries and New Releases Lead to Mixed Res
[ Mon, Jul 30th 2012 ] - Market Wire
USANA Health Sciences Continues to Reduce its Carbon Footprint
[ Mon, Jul 30th 2012 ] - Market Wire
OncoSec Receives ISO 13485 Quality Management System Certification
[ Mon, Jul 30th 2012 ] - Market Wire
Comprehensive Care Corporation Retained by CHRIST .. to Provide Behavioral Health Management Services
[ Mon, Jul 30th 2012 ] - Market Wire
Eisai and Arena Pharmaceuticals Complete Transfer of BELVIQ (lorcaserin HCl) New Drug Application
Sun, July 29, 2012
[ Sun, Jul 29th 2012 ] - Market Wire
Basilea submits European Marketing Authorization .. on of ceftobiprole for the treatment of pneumonia
[ Sun, Jul 29th 2012 ] - Market Wire
Clinical Research on Accuray's CyberKnife and Tom .. nted at Key Industry Event for Medical Physicists
Fri, July 27, 2012
[ Fri, Jul 27th 2012 ] - Market Wire
Harvard and MIT Students Rally Boston to Join Glo .. nness World Record Attempt on World Hepatitis Day
[ Fri, Jul 27th 2012 ] - Market Wire
Bacterin International Holdings, Inc. Schedules S .. d Quarter 2012 Financial Earnings Conference Call
[ Fri, Jul 27th 2012 ] - Market Wire
Insulet Corporation to Report Second Quarter 2012 Financial Results on August 8, 2012
[ Fri, Jul 27th 2012 ] - Market Wire
Sarepta Therapeutics Regains NASDAQ Compliance
[ Fri, Jul 27th 2012 ] - Market Wire
Equity Research on WellPoint Inc. and CIGNA Corp. - Tough Times for Insurers
[ Fri, Jul 27th 2012 ] - Market Wire
Santa Fe Petroleum, Inc. Announces the Appointmen .. om Griffin as President and Chairman of the Board
[ Fri, Jul 27th 2012 ] - Market Wire
Hansen Medical Announces Second Quarter 2012 Results Conference Call
[ Fri, Jul 27th 2012 ] - Market Wire
Micro Imaging Technology Introduces the MIT 1000 to Food Safety Industry Professionals
[ Fri, Jul 27th 2012 ] - Market Wire
Aethlon Medical Announces the Appointment of Thom .. nham and Philip A. Ward to its Board of Directors
[ Fri, Jul 27th 2012 ] - Market Wire
Mylan Launches Generic Version of Sporanox Capsules
Thu, July 26, 2012
[ Thu, Jul 26th 2012 ] - Market Wire
NuPathe Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
[ Thu, Jul 26th 2012 ] - Market Wire
Once-Daily Dolutegravir is Non-Inferior to Twice- .. Raltegravir in Treatment-Naive Adults with HIV-1
[ Thu, Jul 26th 2012 ] - Market Wire
Securities Lawyers at Goldfarb LLP Seeking More M .. n for Stockholders of Human Genome Sciences, Inc.
[ Thu, Jul 26th 2012 ] - Market Wire
Merck Recognizes World Hepatitis Day With Partner .. o Support Global and U.S. Hepatitis C Communities
[ Thu, Jul 26th 2012 ] - Market Wire
Notice of Paladin Labs' Second Quarter 2012 Results Conference Call
[ Thu, Jul 26th 2012 ] - Market Wire
Unigene Provides Update Following Recent EMA Recommendation on Calcitonin-Containing Medicines
[ Thu, Jul 26th 2012 ] - Market Wire
Cytori to Webcast Second Quarter Financial Results on August 8
[ Thu, Jul 26th 2012 ] - Market Wire
Preclinical Data for AEZS-108 in Bladder Cancer Published Online in Oncotarget
[ Thu, Jul 26th 2012 ] - Market Wire
Digirad Corporation Reports 2012 Second Quarter and Six-Month Financial Results
[ Thu, Jul 26th 2012 ] - Market Wire
Alimera Sciences' ILUVIEN Receives Marketing Auth .. r the Treatment of Chronic Diabetic Macular Edema
Wed, July 25, 2012
[ Wed, Jul 25th 2012 ] - Market Wire
Quick-Med Receives Patent for Enhancing the Antim .. ce of NIMBUS(R) Contact Lenses and Other Surfaces
[ Wed, Jul 25th 2012 ] - Market Wire
BIOLASE Establishes Inside Sales Group
[ Wed, Jul 25th 2012 ] - Market Wire
Genomic Health Announces Publication of Clinical .. marker Discovery Using Next Generation Sequencing
[ Wed, Jul 25th 2012 ] - Market Wire
NuPathe Appoints Armando Anido as Chief Executive Officer
[ Wed, Jul 25th 2012 ] - Market Wire
EntreMed Announces Initiation Of Phase 2 Trial In Triple-negative Breast Cancer
[ Wed, Jul 25th 2012 ] - Market Wire
Acura Pharmaceuticals to Host Second Quarter 2012 .. nancial Results Conference Call on August 8, 2012
[ Wed, Jul 25th 2012 ] - Market Wire
Implant Sciences Wins Contracts to Supply Additio .. s to China for Use by China Police and Bomb Squad
[ Wed, Jul 25th 2012 ] - Market Wire
EnteroMedics to Host Second Quarter 2012 Financia .. sults Conference Call and Provide Business Update
[ Wed, Jul 25th 2012 ] - Market Wire
STATS ChipPAC Appoints Gary Tanner as Director
[ Wed, Jul 25th 2012 ] - Market Wire
Sunshine Heart Announces CE Mark for C-Pulse(R) Heart Assist System
Tue, July 24, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
ViroPharma To Release 2012 Second Quarter Financial Results On August 9, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Anthera Pharmaceuticals Announces Exercise in Ful .. and Completion of Public Offering of Common Stock
[ Tue, Jul 24th 2012 ] - Market Wire
Winner Medical Enters into Definitive Merger Agreement with Winner Holding Limited
[ Tue, Jul 24th 2012 ] - Market Wire
BIOLASE Announces Opening of Corporate Technology and Training Center
[ Tue, Jul 24th 2012 ] - Market Wire
Rosetta Genomics and Precision Therapeutics Enter .. Co-Marketing Agreement for miRview mets(2) Assay
[ Tue, Jul 24th 2012 ] - Market Wire
Neogen reports year end results
[ Tue, Jul 24th 2012 ] - Market Wire
Nephros Announces Expansion of U.S. Sales Team
[ Tue, Jul 24th 2012 ] - Market Wire
Auxilium Pharmaceuticals to Announce Second Quart .. Conduct Conference Call on Tuesday, July 31, 2012
[ Tue, Jul 24th 2012 ] - Market Wire
Enzalutamide Granted Priority Review by U.S. FDA .. f Castration-Resistant Prostate Cancer in Patient
[ Tue, Jul 24th 2012 ] - Market Wire
Sarepta Therapeutics Announces Significant Clinic .. ter 36 Weeks in Phase IIb Study for the Treatment
Mon, July 23, 2012
[ Mon, Jul 23rd 2012 ] - Market Wire
Sanofi US Launches Collaborate Activate Innovation Challenge
[ Mon, Jul 23rd 2012 ] - Market Wire
Sarepta Announces Conference Call and Webcast on .. scuss 36-Week 6-Minute Walk Test Results From the
[ Mon, Jul 23rd 2012 ] - Market Wire
Savient Pharmaceuticals Receives Favorable Decision In Tang Capital Litigation
[ Mon, Jul 23rd 2012 ] - Market Wire
Ronald L. Chez Files Amended 13D and Letter to the Board
[ Mon, Jul 23rd 2012 ] - Market Wire
Implant Sciences Extends Global Distribution Network Into Switzerland
[ Mon, Jul 23rd 2012 ] - Market Wire
InternetArray Appoints StockPlay Director of Marketing
[ Mon, Jul 23rd 2012 ] - Market Wire
Mexico Grants Quick-Med Technologies Additional NIMBUS(R) Patent
[ Mon, Jul 23rd 2012 ] - Market Wire
Life Technologies Develops Simplified SAME-DAY ST .. ecting Multiple Strains of E. coli in Ground Beef
[ Mon, Jul 23rd 2012 ] - Market Wire
Trimel Completes Patient Enrolment of CompleoTRT(TM) Phase III Trial
[ Mon, Jul 23rd 2012 ] - Market Wire
BioLife Solutions Completes Corporate Facilities .. of Additional cGMP Clean Room Manufacturing Suite
Sun, July 22, 2012
[ Sun, Jul 22nd 2012 ] - Market Wire
Basilea announces completion of Toctino(R) (alitretinoin) transaction with Stiefel
Sat, July 21, 2012
[ Sat, Jul 21st 2012 ] - Market Wire
Faruqi & Faruqi, LLP Encourages Investors Who Suf .. 0,000 Investing in Centene Corporation To Contact
Fri, July 20, 2012
[ Fri, Jul 20th 2012 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. cess of $100,000 Investing in Centene Corporation
[ Fri, Jul 20th 2012 ] - Market Wire
AcelRx Pharmaceuticals, Inc. Investor Presentatio .. n-demand Viewing at RetailInvestorConferences.com
[ Fri, Jul 20th 2012 ] - Market Wire
Onyx Pharmaceuticals Receives FDA Accelerated Approval of Kyprolisa" (carfilzomib) for Injection
[ Fri, Jul 20th 2012 ] - Market Wire
Positron Accepts Economic Incentives Offer From T .. For $30 Million Towards 70 MeV Cyclotron Project
[ Fri, Jul 20th 2012 ] - Market Wire
CONMED Corporation and Exactech to Partner in Nor .. Medical Education Programs to Treat the Continuum
[ Fri, Jul 20th 2012 ] - Market Wire
Equity Research on DaVita Inc. and HEALTHSOUTH Co .. pecialized Health Providers Enjoying Grace Period
[ Fri, Jul 20th 2012 ] - Market Wire
Arena Pharmaceuticals and VIVUS Competitors in the Lucrative Anti-Obesity Drug Market
[ Fri, Jul 20th 2012 ] - Market Wire
Competition in the Anti-Obesity Drug Market Growi .. as FDA Approves Second Weight Loss Drug This Year
Thu, July 19, 2012
[ Thu, Jul 19th 2012 ] - Market Wire
Amerigroup Honored by American Red Cross
[ Thu, Jul 19th 2012 ] - Market Wire
Whiteknight Acquisitions Inc. Announces Commencem .. sing of Its Qualifying Transaction and Concurrent
[ Thu, Jul 19th 2012 ] - Market Wire
Rochester Medical Announces Third Quarter 2012 Earnings Conference Call Friday, July 27, 2012
[ Thu, Jul 19th 2012 ] - Market Wire
Thallion Announces Sale of its Stake in Caprion Proteomics
[ Thu, Jul 19th 2012 ] - Market Wire
Gentiva Health Services Schedules Second Quarter .. ngs Call And Webcast For Thursday, August 2, 2012
[ Thu, Jul 19th 2012 ] - Market Wire
Sarepta's Marburg Virus Drug Shows Survival in Primates Despite Delayed Treatment
[ Thu, Jul 19th 2012 ] - Market Wire
ImmuCell Receives Effectiveness Technical Section Complete Letter From FDA for Mast Out(R)
[ Thu, Jul 19th 2012 ] - Market Wire
Life Technologies Signs Collaborative Agreement w .. rtium to Develop First Antibody Master Set for Ep
[ Thu, Jul 19th 2012 ] - Market Wire
Helix BioPharma Corp. Announces Filing of Form 15F to Terminate SEC Reporting Obligations
[ Thu, Jul 19th 2012 ] - Market Wire
PDL BioPharma to Announce Second Quarter 2012 Financial Results on August 2, 2012
Wed, July 18, 2012
[ Wed, Jul 18th 2012 ] - Market Wire
Alexza Announces Submission of Responses to the E .. A Day 120 List of Questions for the ADASUVEa" MAA
[ Wed, Jul 18th 2012 ] - Market Wire
Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
[ Wed, Jul 18th 2012 ] - Market Wire
Sangamo BioSciences Announces Second Quarter 2012 Conference Call and Webcast
[ Wed, Jul 18th 2012 ] - Market Wire
Given Imaging to Host Second Quarter 2012 Financial Results Conference Call on August 8, 2012
[ Wed, Jul 18th 2012 ] - Market Wire
Cynapsus Announces Closing of Private Placement
[ Wed, Jul 18th 2012 ] - Market Wire
Vivakor Announces Acquisition of Nutraceutical Product Line Technology and Distribution
[ Wed, Jul 18th 2012 ] - Market Wire
STATS ChipPAC Honours Top Suppliers for Excellent Performance and Outstanding Support
[ Wed, Jul 18th 2012 ] - Market Wire
Daxor Announces Placement of BVA-100 Blood Volume .. ew York Presbyterian/Weill Cornell Medical Center
[ Wed, Jul 18th 2012 ] - Market Wire
Cytomedix Announces Collaboration With Duke Unive .. e I Clinical Study of ALD-451 in Malignant Glioma
[ Wed, Jul 18th 2012 ] - Market Wire
Neogen Corporation Announces Year-End Results Conference Call

Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 20


//health-fitness.news-articles.net/content/2012/ .. lts-for-the-second-quarter-ended-june-30-20.html
Published in Health and Fitness on Tuesday, July 31st 2012 at 13:46 GMT by Market Wire   Print publication without navigation


Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for... -- SAN DIEGO, July 31, 2012 /PRNewswire/ --

Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012

[ ]

SAN DIEGO, July 31, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: [ OREX ]), a biopharmaceutical company focused on the treatment of obesity, will announce financial results for the second quarter ended June 30, 2012 on Tuesday, August 7, 2012 before the markets open. The announcement will be followed by a live webcast and conference call at 8:30 a.m. Eastern time (5:30 a.m. Pacific time).

Orexigen management will host the call and webcast to discuss financial results and recent business highlights. The live call may be accessed by phone by calling (888) 771-4371 (domestic) or (847) 585-4405 (international), participant code 33012560. The webcast can be accessed live on the investor relations section of the Orexigen web site at [ www.orexigen.com ] and will be archived for 14 days following the call.

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment (SPA) for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at [ www.orexigen.com ].

McDavid Stilwell
Vice President, Corporate Communications & Business Development
858-875-8600

 

SOURCE Orexigen Therapeutics, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.orexigen.com ]


Publication Contributing Sources